시장보고서
상품코드
1262802

세계의 H1N1 백신 시장 리포트(2023년)

H1N1 Vaccine Global Market Report 2023

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 200 Pages | 배송안내 : 2-10일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

H1N1 백신 세계 시장은 2022년 29억 4,000만 달러에서 2023년에는 31억 4,000만 달러로 CAGR 7.0%로 성장할 것으로 예측됩니다. 러시아 우크라이나 전쟁은 적어도 단기적으로 COVID-19 팬데믹으로부터의 세계 경제 회복 가능성을 혼란시켰습니다. 이 두 국가 간의 전쟁은 여러 국가에 대한 경제 제재, 상품 가격 상승, 공급망 혼란으로 이어졌으며, 상품과 서비스 전반에 인플레이션을 일으켜 전세계 많은 시장에 영향을 미쳤습니다. H1N1 백신 시장은 2027년 CAGR 6.5%로 40억 4,000만 달러로 성장할 것으로 예상됩니다.

2022년 H1N1 백신 시장에서는 북미가 가장 큰 지역이 되었습니다. H1N1 백신 시장 보고서의 대상 지역은 아시아태평양, 서유럽, 동유럽, 북미, 남미, 중동 및 아프리카입니다.

면역학 및 백신 분야에서 R&D 활동에 대한 지출 증가는 향후 H1N1 백신 시장의 성장을 촉진할 것으로 예상됩니다. 면역학과 백신은 감염을 예방하고 감염과 싸우는 항체 생산을 돕는 데 사용됩니다. 면역학은 면역계의 이해에 중점을 둔 의학·생물학 분야의 중요한 연구 분야입니다. H1N1 백신은 다양한 질병에 대한 면역을 제공하는 항체 생산을 향상시키는 데 사용되는 제형입니다. 예를 들어 유럽을 거점으로 건강산업에서 연구 기반의 혁신을 지원하는 비영리단체 kENUP Foundation의 기사에 따르면 2021년 1월 세계적으로 유행이 시작된 이래 각국 정부는 백신과 치료법 개발에 최소 941억 1,000만 달러(930억 유로)를 지출했습니다. 공공부문은 불과 11개월간 총 지출의 95%에 해당하는 875억 4,000만 달러(865억 유로)를 예방접종 개발에 투입하고 있습니다. 따라서 면역학과 백신 분야에서 R&D 활동에 대한 지출의 증가는 H1N1 백신 시장의 성장을 이끌고 있습니다.

신종 인플루엔자 감염의 급증은 향후 H1N1 백신 시장의 성장을 촉진할 것으로 예상됩니다. H1N1형 인플루엔자는 A형 인플루엔자 바이러스의 일종으로, 숙주에게 상기도 감염증, 경우에 따라서는 하기도 감염증을 일으키는 감염성의 바이러스성 질환입니다. H1N1 백신은 인플루엔자 A(H1N1)에 의한 감염을 예방하기 위해 1회 0.5 mL의 근육내 주사로서 투여되어야 합니다. 또한 신체에서이 질병에 대한 항체를 만드는 데 도움이됩니다. 예를 들어 인도를 기반으로 하는 일간지인 'Times of India'에 따르면 2022년 8월 현재 마하라슈트라주에서 H1N1 인플루엔자 1,500명 가까운 감염자와 43명의 사망자가 보고되고 있습니다. 게다가 미국을 거점으로 하는 정부보건기관인 질병관리예방센터에 따르면 2021년 10월 35,47,791건의 검사 중 인플루엔자의 양성반응이 나온 사람은 1,356명으로 그 중 인플루엔자 A에 감염된 사람은 1,328명, B독감 감염자는 2237명이었습니다. 따라서 H1N1 감염의 증가는 H1N1 백신 시장의 성장으로 이어집니다.

목차

제1장 주요 요약

제2장 H1N1 백신 시장의 특징

제3장 H1N1 백신 시장 동향과 전략

제4장 H1N1 백신 시장 - 매크로 경제 시나리오

  • H1N1 백신 시장에 대한 COVID-19의 영향
  • 우크라이나와 러시아의 전쟁이 H1N1 백신 시장에 미치는 영향
  • H1N1 백신 시장에 대한 고인플레이션의 영향

제5장 H1N1 백신 시장 규모와 성장

  • 세계의 H1N1 백신 시장 실적, 2017-2022년
    • 시장의 촉진요인
    • 시장의 억제요인
  • 세계 H1N1 백신 시장 예측, 2022-2027F, 2032F
    • 시장의 촉진요인
    • 시장의 억제요인

제6장 H1N1 백신 시장 세분화

  • 세계의 H1N1 백신 시장, 제품 유형별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 불활화 백신
  • 약독생 백신
  • 세계의 H1N1 백신 시장, 투여 경로별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 피내 백신 접종
  • 근육내 백신 접종
  • 피하접종
  • 세계의 H1N1 백신 시장, 최종사용자별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 병원
  • 진료소
  • 조사 및 진단 연구소
  • 기타 최종사용자

제7장 H1N1 백신 시장의 지역 및 국가 분석

  • 세계의 H1N1 백신 시장, 지역별, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 세계의 H1N1 백신 시장, 국가별, 실적과 예측, 2017-2022, 2022-2027F, 2032F

제8장 아시아태평양 H1N1 백신 시장

  • 아시아태평양의 H1N1 백신 시장 개요
  • 지역 정보, COVID-19의 영향, 시장 정보, 배경 정보, 정부의 이니셔티브, 규제, 규제 기관, 주요 단체, 과세되는 세, 법인세 구조, 투자, 주요 기업
  • 아시아태평양의 H1N1 백신 시장, 제품 유형별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 아시아태평양 H1N1 백신 시장, 최종사용자별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F

제9장 중국 H1N1 백신 시장

  • 중국 H1N1 백신 시장 개요
  • 중국 H1N1 백신 시장, 제품 유형별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 중국의 H1N1 백신 시장, 최종사용자별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F

제10장 인도의 H1N1 백신 시장

  • 인도의 H1N1 백신 시장, 제품 유형별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 인도의 H1N1 백신 시장, 최종사용자별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F

제11장 일본의 H1N1 백신 시장

  • 일본의 H1N1 백신 시장, 제품 유형별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 일본 H1N1 백신 시장, 최종사용자별 세분화, 과거와 예측, 2017-2022, 2022-2027F, 2032F

제12장 호주 H1N1 백신 시장

  • 호주 H1N1 백신 시장, 제품 유형별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 호주 H1N1 백신 시장, 최종사용자별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F

제13장 인도네시아 H1N1 백신 시장

  • 인도네시아 H1N1 백신 시장, 제품 유형별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 인도네시아 H1N1 백신 시장, 최종사용자별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F

제14장 한국의 H1N1 백신 시장

  • 한국의 H1N1 백신 시장, 제품 유형별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 한국의 H1N1 백신 시장, 최종사용자별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F

제15장 서유럽 H1N1 백신 시장

  • 서유럽 H1N1 백신 시장 개요
  • 서유럽 H1N1 백신 시장, 제품 유형별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 서유럽 H1N1 백신 시장, 최종사용자별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F

제16장 영국 H1N1 백신 시장

  • 영국 H1N1 백신 시장, 제품 유형별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 영국 H1N1 백신 시장, 최종사용자별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F

제17장 독일 H1N1 백신 시장

  • 독일 H1N1 백신 시장, 제품 유형별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 독일 H1N1 백신 시장, 최종사용자별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F

제18장 프랑스 H1N1 백신 시장

  • 프랑스 H1N1 백신 시장, 제품 유형별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 프랑스 H1N1 백신 시장, 최종사용자별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F

제19장 동유럽 H1N1 백신 시장

  • 동유럽 H1N1 백신 시장 개요
  • 동유럽 H1N1 백신 시장, 제품 유형별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 동유럽 H1N1 백신 시장, 최종사용자별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F

제20장 러시아 H1N1 백신 시장

  • 러시아 H1N1 백신 시장, 제품 유형별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 러시아 H1N1 백신 시장, 최종사용자별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F

제21장 북미 H1N1 백신 시장

  • 북미 H1N1 백신 시장 개요
  • 북미 H1N1 백신 시장, 제품 유형별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 북미 H1N1 백신 시장, 최종사용자별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F

제22장 미국 H1N1 백신 시장

  • 미국 H1N1 백신 시장 개요
  • 미국 H1N1 백신 시장, 제품 유형별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 미국 H1N1 백신 시장, 최종사용자별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F

제23장 남미 H1N1 백신 시장

  • 남미 H1N1 백신 시장 개요
  • 남미 H1N1 백신 시장, 제품 유형별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 남미 H1N1 백신 시장, 최종사용자별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F

제24장 브라질 H1N1 백신 시장

  • 브라질 H1N1 백신 시장, 제품 유형별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 브라질 H1N1 백신 시장, 최종사용자별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F

제25장 중동 H1N1 백신 시장

  • 중동 H1N1 백신 시장 개요
  • 중동 H1N1 백신 시장, 제품 유형별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 중동 H1N1 백신 시장, 최종사용자별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F

제26장 아프리카 H1N1 백신 시장

  • 아프리카 H1N1 백신 시장 개요
  • 아프리카 H1N1 백신 시장, 제품 유형별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 아프리카 H1N1 백신 시장, 최종사용자별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F

제27장 H1N1 백신 시장 경쟁 상황 및 기업 개요

  • H1N1 백신 시장의 경쟁 상황
  • H1N1 백신 시장의 기업 개요
    • Sanofi
    • Novartis AG
    • GlaxoSmithKline plc
    • CSL Limited
    • AstraZeneca

제28장 H1N1 백신 시장의 주요 합병 및 인수

제29장 H1N1 백신 시장의 향후 전망과 가능성 분석

제30장 부록

ksm 23.05.04

“H1N1 Vaccine Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on h1n1 vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for h1n1 vaccine? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The h1n1 vaccine market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product Type: Inactivated Vaccine; Live Attenuated Vaccine
  • 2) By Route Of Administration: Intradermal Vaccination; Intramuscular Vaccination; Subcutaneous Vaccination
  • 3) By End Users: Hospitals; Clinics; Research and Diagnostic Laboratories; Other End Users
  • Companies Mentioned: Sanofi; Novartis AG; GlaxoSmithKline plc; CSL Limited; AstraZeneca
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the H1N1 vaccine market are: Sanofi, Novartis AG, GlaxoSmithKline plc, CSL Limited, AstraZeneca, Zydus Cadila, Merck and Co.Inc., NovavaxInc., Baxter, Panacea Biotec Ltd., Sinovac Biotech Ltd., Green Cross Corp., Abbott, Pfizer Inc., Mitsubishi Tanabe Pharma Corporation., Seqirus, and Cipla Inc.

The global H1N1 vaccine market is expected to grow from $2.94 billion in 2022 to $3.14 billion in 2023 at a compound annual growth rate (CAGR) of 7.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The H1N1 vaccine market is expected to grow to $4.04 billion in 2027 at a CAGR of 6.5%.

The H1N1 vaccines market consists of sales of TIV (flu shot (injection) and LAIV (nasal spray (mist) of live attenuated influenza vaccine). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

H1N1 vaccines are administered to people six months of age and older to immunize them against influenza diseases brought on by the H1N1 2009 virus. These are used to prevent humans from Influenza virus infection by injecting a small dose of the virus inside the body to build immunity against the virus.

North America was the largest region in the H1N1 vaccine market in 2022. The regions covered in the H1N1 vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main product types of H1N1 vaccine are inactivated vaccine, and live attenuated vaccine. The inactivated vaccine market consists of sales of H1N1 vaccine products that are used to prevent disease caused by the influenza H1N1 virus. Inactivated vaccine is a synthetic vaccine with protective immunising action that contains hemagglutinin (HA) antigens generated from four inactivated influenza viruses, including two different influenza type. A strains and two different influenza type B strains. The various routes of administration include intradermal vaccination, intramuscular vaccination, and subcutaneous vaccination which are used by various end users such as hospitals, clinics, research and diagnostic laboratories, and others.

Increasing expenditure for research and development activities in the field of immunology and vaccine is expected to propel the growth of the H1N1 vaccine market going forward. Immunology and vaccine are used to prevent infections and help in producing antibodies to fight infections. Immunology is a crucial area of research in the medical and biological sciences that focuses on understanding the immune system. The H1N1 vaccine is a preparation used to boost antibody production, which provides immunity against a variety of diseases. For instance, according to an article by the kENUP Foundation, a Europe-based non-profit supporting research-based innovation in health industries, in January 2021, governments spent at least $94.11 billion (€93 billion) on the development of vaccines and treatments since the start of the pandemic worldwide. The public sector committed 95% of the total spending, or $87.54 billion (€86.5 billion), in just 11 months to the development of vaccinations. Therefore, increasing expenditure for research and development activities in the field of immunology and vaccine is driving the growth of the H1N1 vaccine market.

An upsurge in the spread of H1N1 infection is expected to propel the growth of the H1N1 vaccine market going forward. H1N1 influenza refers to a subtype of influenza A virus, a communicable viral illness that causes upper and, in some cases, lower respiratory tract infections in its host. The H1N1 vaccine should be administered as a single 0.5-mL intramuscular injection that helps to prevent infection caused by influenza A (H1N1). Also, helps the body produce its own antibodies against the disease. For instance, according to the Times of India, an India-based daily newspaper, as of August 2022, nearly H1N1 influenza 1,500 cases and 43 deaths have been reported in Maharashtra in the year 2022. Further, according to the Center for Disease Control and Prevention, a US-based government health organization, in October 2021, there were 1,35,046 people tested positive for influenza out of 35,47,791 tests, out of which 1,32,809 were affected by influenza A and 2,237 were affected by influenza B. Therefore, an upsurge in the spread of H1N1 infection is driving the growth of the H1N1 vaccine market.

Strategic collaborations between companies is a key trend that is gaining popularity in the H1N1 (swine flu) vaccination market. Companies in the H1N1 (swine flu) Vaccination market are focusing on strategic collaborations to expand their market share. For instance, in August 2022, A significant, a pharmaceutical company and Open Orphan affiliate hVIVO have agreed to an agreement for $123 million to create a brand-new batch of H1N1 influenza challenge virus. This has stimulated the growth potential of both companies in the industry.

The countries covered in the H1N1 vaccine market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The H1N1 vaccine report is one of a series of new reports from The Business Research Company that provides H1N1 vaccine statistics, including H1N1 vaccine industry global market size, regional shares, competitors with an H1N1 vaccine share, detailed H1N1 vaccine segments, market trends and opportunities, and any further data you may need to thrive in the H1N1 vaccine industry. This H1N1 vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Table of Contents

1. Executive Summary

2. H1N1 Vaccine Market Characteristics

3. H1N1 Vaccine Market Trends And Strategies

4. H1N1 Vaccine Market - Macro Economic Scenario

  • 4.1. COVID-19 Impact On H1N1 Vaccine Market
  • 4.2. Ukraine-Russia War Impact On H1N1 Vaccine Market
  • 4.3. Impact Of High Inflation On H1N1 Vaccine Market

5. H1N1 Vaccine Market Size And Growth

  • 5.1. Global H1N1 Vaccine Historic Market, 2017-2022, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global H1N1 Vaccine Forecast Market, 2022-2027F, 2032F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. H1N1 Vaccine Market Segmentation

  • 6.1. Global H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Inactivated Vaccine
  • Live Attenuated Vaccine
  • 6.2. Global H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Intradermal Vaccination
  • Intramuscular Vaccination
  • Subcutaneous Vaccination
  • 6.3. Global H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Hospitals
  • Clinics
  • Research and Diagnostic Laboratories
  • Other End Users

7. H1N1 Vaccine Market Regional And Country Analysis

  • 7.1. Global H1N1 Vaccine Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 7.2. Global H1N1 Vaccine Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific H1N1 Vaccine Market

  • 8.1. Asia-Pacific H1N1 Vaccine Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 8.3. Asia-Pacific H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China H1N1 Vaccine Market

  • 9.1. China H1N1 Vaccine Market Overview
  • 9.2. China H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
  • 9.3. China H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India H1N1 Vaccine Market

  • 10.1. India H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 10.2. India H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan H1N1 Vaccine Market

  • 11.1. Japan H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 11.2. Japan H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia H1N1 Vaccine Market

  • 12.1. Australia H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 12.2. Australia H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia H1N1 Vaccine Market

  • 13.1. Indonesia H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 13.2. Indonesia H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea H1N1 Vaccine Market

  • 14.1. South Korea H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 14.2. South Korea H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe H1N1 Vaccine Market

  • 15.1. Western Europe H1N1 Vaccine Market Overview
  • 15.2. Western Europe H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 15.3. Western Europe H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK H1N1 Vaccine Market

  • 16.1. UK H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 16.2. UK H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany H1N1 Vaccine Market

  • 17.1. Germany H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 17.2. Germany H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France H1N1 Vaccine Market

  • 18.4. France H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 18.5. France H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe H1N1 Vaccine Market

  • 19.1. Eastern Europe H1N1 Vaccine Market Overview
  • 19.2. Eastern Europe H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 19.3. Eastern Europe H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia H1N1 Vaccine Market

  • 20.1. Russia H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 20.2. Russia H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America H1N1 Vaccine Market

  • 21.1. North America H1N1 Vaccine Market Overview
  • 21.2. North America H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 21.3. North America H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA H1N1 Vaccine Market

  • 22.1. USA H1N1 Vaccine Market Overview
  • 22.2. USA H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 22.3. USA H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America H1N1 Vaccine Market

  • 23.1. South America H1N1 Vaccine Market Overview
  • 23.2. South America H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 23.3. South America H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil H1N1 Vaccine Market

  • 24.1. Brazil H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 24.2. Brazil H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East H1N1 Vaccine Market

  • 25.1. Middle East H1N1 Vaccine Market Overview
  • 25.2. Middle East H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 25.3. Middle East H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa H1N1 Vaccine Market

  • 26.1. Africa H1N1 Vaccine Market Overview
  • 26.2. Africa H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 26.3. Africa H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. H1N1 Vaccine Market Competitive Landscape And Company Profiles

  • 27.1. H1N1 Vaccine Market Competitive Landscape
  • 27.2. H1N1 Vaccine Market Company Profiles
    • 27.2.1. Sanofi
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Novartis AG
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. GlaxoSmithKline plc
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. CSL Limited
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. AstraZeneca
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The H1N1 Vaccine Market

29. H1N1 Vaccine Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Historic And Forecast Inflation Rates
  • 30.4. Research Inquiries
  • 30.5. The Business Research Company
  • 30.6. Copyright And Disclaimer
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제